Skip to main content
. Author manuscript; available in PMC: 2009 Apr 6.
Published in final edited form as: Circ Res. 2006 Nov 9;99(12):1426–1432. doi: 10.1161/01.RES.0000251668.39526.c7

Figure 4.

Figure 4

Correlation of Rho kinase inhibition with fasudil and change in endothelium-dependent vasodilation. For the entire cohort of 28 patients, the change in flow-mediated, endothelium-dependent vasodilation after fasudil relative to placebo was inversely proportional to the extent of Rho kinase inhibition with fasudil (r=−0.48, P=0.01). Squares represent CAD and triangles represent healthy subjects, respectively.